Pilot Open Label Use of the Hi-OXSR for the Treatment of Post COVID-19 Cognitive Dysfunction

Conditions: Post COVID-19 Condition Interventions: Device: Hi-OxSR Sequential Rebreathing mask (oxygen concentrator) Sponsors: University Health Network, Toronto Completed

https://clinicaltrials.gov/study/NCT06379620

Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials

More News: COVID-19 | Research